IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q4 2020 Holdings

Filed 2021-03-01 | 15 holdings | $292.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte(PCVX)Common92243G108$110.7K4,168,71837.9%
Spruce BioCommonE5209E109$43.1K1,792,51814.7%
Phathom(PHAT)Common71722W107$40.0K1,203,13513.7%
SolenoCommon834203200$19.9K10,302,6026.8%
Verona(VRNA)SPONDS ADR925050106$16.9K2,457,4995.8%
NucanaADS67022C106$15.0K3,333,3335.1%
Sierra OncologyCommon82640U107$13.9K871,1254.8%
Exicure(XCUR)Common30205M101$12.3K6,977,0004.2%
SientraCommon82621J105$9.3K2,390,8433.2%
ParatekCommon699374302$6.5K1,041,1312.2%
Aeglea(AGLEUSD)Common00773J103$1.9K240,5000.6%
Molecular TemplatesCommon608550109$1.9K200,0000.6%
Cymabay(CBAYUSD)Common23257D103$752131,0360.3%
ObsevaCommonH5861P103$18287,9990.1%
OcugenCommon43358V109$137,1110.0%